CLINICAL_TRIALS
trial_result
· 2018-04-05
Clinical Trial Update: Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern Cambodia
Summary
The update reports Plasmodium falciparum clearance rates following artesunate treatment in eastern Cambodia. The study is sponsored by NIAID and focuses on mala…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Status: COMPLETED